Compare CLDX & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | PARR |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1995 | 2000 |
| Metric | CLDX | PARR |
|---|---|---|
| Price | $29.00 | $45.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | $44.50 | ★ $46.20 |
| AVG Volume (30 Days) | 813.3K | ★ 926.7K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1313.56 |
| EPS | N/A | ★ 7.16 |
| Revenue | $12,743,000.00 | ★ $2,443,066,000.00 |
| Revenue This Year | $97.61 | N/A |
| Revenue Next Year | $252.01 | N/A |
| P/E Ratio | ★ N/A | $6.44 |
| Revenue Growth | ★ 87.78 | 30.99 |
| 52 Week Low | $14.40 | $11.86 |
| 52 Week High | $31.31 | $48.40 |
| Indicator | CLDX | PARR |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 65.84 |
| Support Level | $24.70 | $33.67 |
| Resistance Level | $30.50 | $47.98 |
| Average True Range (ATR) | 1.52 | 2.15 |
| MACD | 0.78 | 0.30 |
| Stochastic Oscillator | 77.87 | 84.18 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.